Table 3. Univariable and multivariable logistic regression for major cardio- and cerebrovascular events (n=2293)
Variable Univariate Univariate Multivariate Multivariate
HR(95%CI) P-value HR(95%CI) P-value
Age 1.042(1.024-1.060) 0.000 1.063(1.028-1.100) 0.000
Female sex 1.195(0.845-1.690) 0.313 1.574(0.852-2.908) 0.148
Persistent AF 1.193(0.845-1.684) 0.316
AF duration* 0.999(0.995-1.004) 0.702
Congestive heart failure 0.359(0.049-2.627) 0.313
Hypertension 1.389(0.985-1.959) 0.061 1.958(1.046-3.665) 0.036
Diabetes mellitus 1.640(1.092-2.463) 0.017 2.938(1.514-5.703) 0.001
Prior stroke/TIA /systemic embolism 0.762(0.405-1.433) 0.400
Vascular disease 1.450(0.988-2.128) 0.057 1.124(0.537-2.357) 0.756
CHA2DS2-VASc score 1.168(1.056-1.293) 0.003 0.494(0.323-0.754) 0.001
HAS-BLED score 1.509(1.196-1.905) 0.001 1.973(1.229-3.167) 0.005
Alcohol consumption 0.797(0.518-1.227) 0.303
LAD ≥ 40 mm 1.454(1.034-2.045) 0.032 1.294(0.838-1.998) 0.244
Obervational period prescription
ACEI/ARB 1.381(0.937-2.034) 0.103
Statins 1.608(1.055-2.451) 0.027 1.387(0.887-2.171) 0.152
Long-term prescription
Oral anticoagulants 1.553(1.051-2.296) 0.027 1.426(0.866-2.349) 0.163
Antiplatelet drugs 1.311(0.909-1.890) 0.147
ACEI/ARB 1.434(1.015-2.026) 0.041 1.030(0.620-1.710) 0.910
Statins 1.294(0.911-1.839) 0.151
Obesity# 1.070(0.735-1.558) 0.723
Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers. Abbreviations: AF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 75 years or older (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years, sex category (female); HAS-BLED, hypertension, abnormal renal or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs or alcohol concomitantly; LAD, left atrial diameter; ACEI, angiotensin converting enzyme inhibitors; ARB, Angiotensin receptor blockers.
since first diagnosis; # BMI ≥28.0 * since first diagnosis; # BMI ≥28.0